TScan Therapeutics, Inc.

NasdaqGM: TCRX · Healthcare

Positivity Index

#3,620 / 6,774

Global

#1,603 / 4,000

United States

Positivity Score

20,402

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 02 Sep 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

TScan Therapeutics, Inc. — Overview & Financial Snapshot

TScan Therapeutics, Inc. (NasdaqGM: TCRX) is a Healthcare company, ranked #3,620 of 6,774 companies globally and #1,603 of 4,000 in United States on PositoAI, with a Positivity Score of 20,402. Its market capitalisation is ₹138.32 Cr ($14.65M), P/E ratio is -0.2 and P/B ratio is 0.21. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does TScan Therapeutics, Inc. do?

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic…

What is TScan Therapeutics, Inc.'s P/E and P/B ratio?

TScan Therapeutics, Inc. has a P/E ratio of -0.2 and a P/B ratio of 0.21.

What is TScan Therapeutics, Inc.'s debt-to-equity ratio?

TScan Therapeutics, Inc. has a debt-to-equity ratio of 1.32.

How much does TScan Therapeutics, Inc. owe compared with what it owns?

TScan Therapeutics, Inc. owes $0.60 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is TScan Therapeutics, Inc.'s Positivity rank?

TScan Therapeutics, Inc. is ranked #3,620 of 6,774 companies globally and #1,603 of 4,000 in United States on PositoAI, with a Positivity Score of 20,402.

Does TScan Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. TScan Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 02 Sep 2026). It has no yellow flags.

Where can I read the latest news about TScan Therapeutics, Inc.?

Recent headlines about TScan Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does TScan Therapeutics, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of TScan Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.